Literature DB >> 12827563

Independent risk factors and natural history of renal dysfunction in liver transplant recipients.

Attaphol Pawarode1, Derek M Fine, Paul J Thuluvath.   

Abstract

Renal dysfunction is common after liver transplantation. However, there are only limited data on the predictors and natural history of renal dysfunction after liver transplantation. In this study, we determined independent predictors and the natural history of renal dysfunction in 172 consecutive liver transplant recipients. Survival and time to development of permanent renal dysfunction (renal dysfunction defined as a sustained decrease in estimated glomerular filtration rate (GFR) of > 30 mL/min/1.73 m(2) from baseline for at least 6 months, severe renal failure defined as absolute GFR <30 mL/min/1.73 m(2) for at least 6 months) were determined using the Kaplan-Meier method. Cox regression analysis was used to test the independent effect of a given set of variables on time to development of such an event. Nine percent of patients required immediate dialysis, 35% developed permanent renal dysfunction, and 7% developed severe renal failure. The rate of decline in renal dysfunction was maximal, 6.5 mL/min/1.73 m(2) /mo, at 1 month after liver transplantation. Pre-existing diabetes mellitus, major surgical infection, and waiting time on the transplant list were independent risk factors for immediate dialysis. Presence of serum creatinine > 1.2 mg/dL at any time before liver transplantation and a baseline GFR <70 mL/min/1.73 m(2) were independent predictors of permanent renal dysfunction. Diabetes mellitus, coronary artery disease, and primary graft nonfunction predicted the development of severe renal failure. GFR stabilized around 9 months, and presence of decreased GFR > 30mL/min/1.73 m(2) from baseline at 9 months predicted development of permanent renal dysfunction. An absolute GFR of <30mL/min/1.73 m(2) occurring as early as 3 months after liver transplantation predicted severe renal failure. Severe renal failure was associated with a significantly lower survival by Cox regression analysis. We have identified risk factors and the natural history of permanent renal dysfunction and severe liver failure in liver transplant recipients. These observations may be useful in the development of nonnephrotoxic immunosuppressive regimens for high-risk liver transplant recipients.

Entities:  

Mesh:

Year:  2003        PMID: 12827563     DOI: 10.1053/jlts.2003.50113

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  43 in total

1.  Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.

Authors:  Zhen-Yong Shao; Lu-Nan Yan; Wen-Tao Wang; Bo Li; Tian-Fu Wen; Jia-Yin Yang; Ming-Qing Xu; Ji-Chun Zhao; Yong-Gang Wei
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease.

Authors:  Arvind Srinath; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-05       Impact factor: 2.839

3.  Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation.

Authors:  Giuseppe Cullaro; Joseph F Pisa; Robert S Brown; Gebhard Wagener; Elizabeth C Verna
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

4.  End-stage kidney disease after pediatric nonrenal solid organ transplantation.

Authors:  Rebecca L Ruebner; Peter P Reese; Michelle R Denburg; Peter L Abt; Susan L Furth
Journal:  Pediatrics       Date:  2013-10-14       Impact factor: 7.124

5.  Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant.

Authors:  José M Álamo; Claudia Olivares; Lydia Barrera; Luis M Marín; Gonzalo Suarez; Carmen Bernal; Juan Serrano; Jordi Muntané; Francisco J Padillo; Miguel A Gómez
Journal:  World J Transplant       Date:  2015-03-24

6.  Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review.

Authors:  William R Hand; Joseph R Whiteley; Tom I Epperson; Lauren Tam; Heather Crego; Bethany Wolf; Kenneth D Chavin; David J Taber
Journal:  Anesth Analg       Date:  2015-03       Impact factor: 5.108

7.  The effect of kidney diseases on survival in liver transplant patients.

Authors:  Inci Süleymanlar; Vural Taner Yılmaz; Hüseyin Koçak; Ayhan Dinçkan; Alihan Gürkan; Fevzi Ersoy; Gültekin Süleymanlar
Journal:  Int Urol Nephrol       Date:  2010-08-05       Impact factor: 2.370

8.  Comparing 10-yr renal outcomes in deceased donor and living donor liver transplants.

Authors:  Shaifali Sandal; Anthony Almudevar; Sandesh Parajuli; Anirban Bose
Journal:  Clin Transplant       Date:  2015-11-05       Impact factor: 2.863

9.  Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies.

Authors:  Yaojen Chang; Lorenzo Gallon; Kirti Shetty; Yuchia Chang; Colleen Jay; Josh Levitsky; Bing Ho; Talia Baker; Daniela Ladner; John Friedewald; Michael Abecassis; Gordon Hazen; Anton I Skaro
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

10.  Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study.

Authors:  Andreas A Schnitzbauer; Marcus N Scherer; Justine Rochon; Johannes Sothmann; Stefan A Farkas; Martin Loss; Edward K Geissler; Aiman Obed; Hans J Schlitt
Journal:  BMC Nephrol       Date:  2010-09-14       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.